Knoll Capital Management, LLC 13F holdings
Knoll Capital Management, LLC reported 37 positions with a total reported value of $214.3M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-09-10. Top holdings by reported value: BHVN Biohaven Pharmactl Hldg Co (16.3%), MGTX MeiraGTX Holdings (7.9%), Sprott physical gold Trust (5.4%), ALDX Aldeyra Therapeutics Inc (5.4%), OCUL Ocular Therapeutix Inc. (5.3%). Against 2026-03-31 it opened 1 new position and exited 1. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Knoll Capital Management, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 37 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| BHVN Biohaven Pharmactl Hldg Co | 2,352,520 | $35.0M | 16.3% |
| MGTX MeiraGTX Holdings | 1,250,000 | $16.9M | 7.9% |
| Sprott physical gold Trust | 387,055 | $11.7M | 5.4% |
| ALDX Aldeyra Therapeutics Inc | 5,475,516 | $11.7M | 5.4% |
| OCUL Ocular Therapeutix Inc. | 1,150,400 | $11.3M | 5.3% |
| RGLD Royal Gold Inc. | 52,750 | $10.5M | 4.9% |
| ENTX Entera Bio Ltd | 5,881,879 | $10.4M | 4.9% |
| NUVB Nuvation Bio Inc | 1,598,591 | $9.1M | 4.2% |
| AEM Agnico Eagle Mines Ltd | 52,750 | $8.2M | 3.8% |
| SA SEABRIDGE GOLD INC | 317,003 | $8.2M | 3.8% |
| KGC Kinross Gold Corp | 320,000 | $7.6M | 3.5% |
| OR OR Royalties | 225,000 | $7.1M | 3.3% |
| SSRM SSR Mining In | 245,000 | $6.9M | 3.2% |
| FNV Franco Nev Corp | 32,000 | $6.7M | 3.1% |
| BAH Booz Allen Hamilton HLDG COR | 13,000 | $5.7M | 2.7% |
| CGAU Centerra Gold Inc | 359,000 | $5.7M | 2.7% |
| ELTX Elicio Therapeutics Inc | 1,211,957 | $4.7M | 2.2% |
| ABVX Abivax SA Spons | 35,000 | $4.7M | 2.2% |
| PAAS Pan American Silver | 100,035 | $4.5M | 2.1% |
| Sprott Physical silver Trust | 222,160 | $4.2M | 2.0% |
| TFPM Triple Flag Precious Metals | 115,000 | $3.4M | 1.6% |
| ABEO Abeona Therapeutics | 485,515 | $3.0M | 1.4% |
| GROY Gold RTY Corp | 1,000,000 | $2.8M | 1.3% |
| New Pac Metals Corp | 485,000 | $1.9M | 0.9% |
| iSHares US Aerospace & Defense | 7,650 | $1.9M | 0.9% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ABVX Abivax SA Spons | 35,000 | $4.7M | 2.2% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 1 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| CRDL Cardiol Therapeutics Inc | 100,000 | $135.0K | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| OCUL Ocular Therapeutix Inc. | 600,400 | 1,150,400 | +91.6% | $11.3M |
| ELTX Elicio Therapeutics Inc | 630,915 | 1,211,957 | +92.1% | $4.7M |
| NUVB Nuvation Bio Inc | 1,498,591 | 1,598,591 | +6.7% | $9.1M |
| BHVN Biohaven Pharmactl Hldg Co | 2,328,602 | 2,352,520 | +1.0% | $35.0M |
| Pharming Group NV | 4,057 | 4,091 | +0.8% | $56.8K |
Decreases
No position was decreased.
CIK 1325083 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
